Medicare Agency to End Some Demonstration Projects, Cancel $2 Generic Drug Initiative
The Centers for Medicare and Medicaid Services plans to terminate four demonstration projects by the end of 2025, closing out ...
The Healthy @Reader's Digest on MSN2d
Almost 37,000 Bottles of a Popular Anxiety and Depression Drug Recalled Nationwide
It's marketed as a generic option to name-brand mood meds, but it's been recalled for the same reason a competitor was just ...
Not All Generics Are Created Equal: Study Exposes a 54% Higher Risk in Indian-Made Drugs
A new study reveals that generic drugs made in India are linked to a significantly higher number of severe adverse events, ...
How prescription drugs get their names
Hint: It's all in the suffix. Viagra, Prozac, Xanax, and Zoloft all went through a process to select memorable names.
India Trade Group Blasts Study Linking Drugs to Safety Risks
A study linking Indian-made generic drugs to a higher risk of serious side effects in the US has drawn backlash from the industry’s most influential lobby group, as India moves to defend its dominant ...
Indian generic drugs linked to deaths in US? Trade group slams study blaming desi pharma
A study found Indian generics sold in the US between 2009-2018 linked to a 54% higher risk of serious side effects compared ...
Pharmaceutical Commerce12d
How a Completely Open Generic Market Could Alter Rx Costs
In the final part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Geoffrey Joyce, PhD, director of ...
Cheaper, generic versions of Ozempic could come to Canada as early as next year
Four companies have applied to Health Canada to sell copies of Ozempic after its market exclusivity expires on Jan. 4, 2026 ...
Rediff Money4d
Indian Generic Drugs Meet Global Standards: IPA
The Indian Pharmaceutical Alliance refutes a study claiming Indian generic drugs have higher adverse events, stating quality ...
Judge Certifies Bellwether Classes in Generic Drug Litigation
A federal judge certified several classes of direct and end-payer purchasers for test trials in drug price-fixing litigation against makers of two generic drugs, clomipramine and clobetasol.
The early winners and losers of Trump’s tariff battle with Canada, Mexico, China and Europe
President Trump is locked in a tit-for-tat tariff war with Canada, Mexico, the European Union and China in a bid to remake ...